- Press Release Distribution

Does managing oxidative stress hold the key to effectively treating Alzheimer’s disease

Supplement to the Journal of Alzheimer’s Disease highlights oxidative stress-based research into potential therapeutic targets and protective drugs for managing Alzheimer’s disease

( Amsterdam, May 21, 2024 – The number of people suffering from Alzheimer’s disease (AD) is expected to reach 100 million by 2050, but there is still no effective therapy. Leading researchers from around the world assess how oxidative stress (OS) may trigger AD and consider potential therapeutic targets and neuroprotective drugs to manage the disease in a collection of articles in a special supplement to the Journal of Alzheimer’s Disease, published by IOS Press.

AD is the most common type of dementia and involves areas of the brain that control thought, memory, and language. It is the most common cause of disability in individuals over 65 years of age and is one of the top 10 leading causes of death in the United States. AD is characterized by the abnormal deposition of amyloid beta peptide and intracellular accumulation of neurofibrillary tangles of hyperphosphorylated tau protein. The diagnosis of AD has recently improved, but its exact cause has not yet been identified. The major challenges are to look beyond the two dominant hypotheses, amyloid beta deposition and tau phosphorylation.

There may be other factors responsible for triggering the disease. Are they triggered by OS, a process referring to an imbalance between antioxidants and oxidants? The OS hypothesis suggests that the brain remains multifunctional as long as “free radicals” produced during various biochemical reactions in the brain are neutralized by antioxidants.

Guest Editor of the supplement Pravat K. Mandal, PhD, Scientist and former Director-in-Charge of the National Brain Research Center, Gurgaon, India, and Honorary Professor, Florey Institute of Neuroscience and Mental Health, Melbourne, Australia, explains: “The OS hypothesis was initiated more than quarter century ago. Recently researchers  have shown renewed interest in investigating the potential benefits of OS neutralization, which had led to the design of numerous trials to examine its effects. As long as there is a balance between the pro-oxidative molecules and antioxidants to neutralize radicals, the brain remains multifunctional and healthy. While there are several of these antioxidants, a prominent one receiving significant attention is glutathione (GSH).”

Analysis based on clinical studies indicates that significant brain GSH depletion in the hippocampus initiates early onset of AD prior to amyloid beta deposition and tau phosphorylation, which is now validated by transgenic animal model study.

The 12 reviews and research articles in this supplement highlight OS-based AD research from several internationally renowned laboratories. Pioneering studies highlight:

Reduced risk of developing AD is associated with dietary intake of antioxidant supplements. Supplementation with GSH, made from the amino acids glycine, cysteine, and glutamic acid, may be neuroprotective and reduce amyloid beta or tau phosphorylation. Significant improvement of working memory in animal models with induced dementia due to Marrubium vulgare extract suggests that it may impact memory preservation. Maintaining diversity in drug development for AD research is important for enhancing the flow of information from randomized clinical trials. “Accumulating evidence from clinical studies leads us to the converging idea that enrichment of brain GSH is the way forward through candidates with superior bioavailability and efficacy,” notes Dr. Mandal.

One contribution explores the neuroprotective effect of combined treatment with epigallocatechin 3-gallate (EGCG) and melatonin (MT) on familial AD. Investigators analyzed the therapeutic potential of a combination of EGCG and MT in a three-dimensional in vitro model of rare familial AD with a mutation in the presenilin-1 gene. The combination of EGCG and MT treatment effectively reduced these pathological markers more efficiently than individual treatments.

Co-lead investigators Marlene Jimenez-Del-Rio, PhD, and Carlos Velez-Pardo, DrSci, both from the Neuroscience Research Group, Medical Research Institute, Faculty of Medicine, University of Antioquia, SIU, Medellin, Colombia, report, “Treatment with a combination of EGCG and MT can be of high therapeutic value due to the high antioxidant capacity and anti-amyloidogenic effect of both compounds compared to individual treatments and deserves further investigation.” Dr. Mandal adds: “Combined therapy of EGCG and MT holds a therapeutic promise for familial AD due to inherent antioxidant capability.”

Other important topics covered in this issue include:

Molecular aspects of aging and age-related disorders Potential therapeutic effects of long-term administration of Tocovid, a novel vitamin E mixture Protective effects of coenzyme Q10 and high-intensity interval training, both individually and in combination Efficacy of docosapentaenoic acid and/or eicosapentaenoic acid supplements in patients with mild cognitive impairment Protective functions of the thioredoxin system and nicotinamide adenine dinucleotide phosphate in the context of AD-induced damage Potential strategies to address early events in AD involving microvascular deterioration in the hippocampus that precedes Aβ deposition Antioxidative and anti-neuroinflammatory effects of Centella asiatica and its triterpene fractions on lipopolysaccharide-induced microglial cells for AD management A computational system pharmacology workflow to uncover the OS triggering AD as well as the potential therapeutic targets and neuroprotective drugs “I anticipate that the OS hypothesis will gain its rightful recognition sooner in AD research to guide drug development tbat will effectively reduce OS and preserve cognitive function,” concludes Dr. Mandal.

“The discovery of OS as upstream to amyloid beta and tau deposition places it at the crossroads of effective therapeutic intervention. Dr. Mandal’s issue explores the state of the science and inspires further development,” adds George Perry, PhD, Semmes Foundation Distinguished University Chair in Neurobiology, The University of Texas at San Antonio, and Editor-in-Chief of JAD.






Warming climate intensifies flash droughts worldwide

Warming climate intensifies flash droughts worldwide
WASHINGTON — Sudden, severe dry spells known as flash droughts are rising in intensity around the world, with a notable exception in mountainous Central Asia, where flash drought extent is shrinking, according to new research. Heat and changes to precipitation patterns caused by a warming climate are driving these trends, the study found. Flash droughts arrive suddenly, within weeks, hitting communities that are often not prepared and causing lasting impact. They are an emerging concern for water and food security. The new study is the first to apply a systematic, quantitative approach to the global incidence of flash drought, mapping hotspots and ...

US public health preparedness and response to highly pathogenic avian influenza A(H5N1) viruses

About The Study: Public health authorities in nearly all states and territories surveyed reported the ability to monitor and test persons exposed to highly pathogenic avian influenza (HPAI) A(H5N1) virus. However, jurisdictions varied in their capacity to monitor exposed persons, in recommendations for use of antivirals, and in potential use of H5N1 vaccines, if available, among first responders.  Corresponding Author: To contact the corresponding author, Noah Kojima, M.D., email To access the embargoed study: Visit our For The Media website at this ...

DRI to host AWE+ wildfire summit

Today, DRI, one of our nation’s leading applied environmental research institutes, together with its Foundation, announced a new global initiative with the first in a series of summits. The event will be held at Encore Las Vegas from August 21-23, 2024. The AWE+ initiative will promote an Adaptable World Environment of strong, resilient communities in a climate shifting world. AWE+ 2024 - Wildfire Recovery and Resilience: Working Across Silos to Drive Solutions - is a global call-to-action for communities ...

MD Anderson Research Highlights for May 21, 2024

HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. Recent developments at MD Anderson offer insights into biomarkers that predict immunotherapy responses, a possible treatment strategy for patients with LKB1-deficient cancers, therapeutic targets to prevent acute myeloid leukemia (AML) progression ...

Polymer research aims to expand possibilities in sensor technology

Polymer research aims to expand possibilities in sensor technology
Sensors enable us to monitor changes in systems of all kinds.  The materials at the heart of those sensors, of course, ultimately determine their end-use application. Devices made of silicon, for example, enable ultrafast processing in computers and phones, but they aren’t pliable enough for use in physiological monitoring.  They also require a lot of energy to produce. Lehigh University professor Elsa Reichmanis, Carl Robert Anderson Chair in the Department of Chemical and Biomolecular Engineering, recently received a grant from the National ...

New therapeutic avenues in bone repair

Birmingham researchers have shown PEPITEM, a naturally occurring peptide (small protein) holds promise as a new therapeutic for osteoporosis and other disorders that feature bone loss, with distinct advantages over existing drugs. PEPITEM (Peptide Inhibitor of Trans-Endothelial Migration) was first identified in 2015 by University of Birmingham researchers.  The latest research, published today in Cell Reports Medicine, show for the first time that PEPITEM could be used as a novel and early clinical intervention to reverse the impact of age-related musculoskeletal diseases, with ...

Socioeconomic status transition throughout life and risk of dementia

About The Study: This cohort study of Japanese older adults identified that upward and downward socioeconomic status transitions were associated with risk of dementia and the length of dementia-free periods over the lifespan. The results may be useful to understand the association between social mobility and healthy longevity.  Corresponding Author: To contact the corresponding author, Hiroyasu Iso, Ph.D., email To access the embargoed study: Visit our For The Media website at this link (doi:10.1001/jamanetworkopen.2024.12303) Editor’s Note: Please see ...

Climbing the social ladder slows dementia, Japanese study reveals

Climbing the social ladder slows dementia, Japanese study reveals
Osaka, Japan – Upward social mobility may ward off dementia, according to a new study. Dementia, a collective term for conditions marked by memory loss and diminished cognitive functioning, strains healthcare systems and devastates quality of life for patients and their families. Research thus far has found correlations between socioeconomic status (SES) – Parent’s asset, education level, income, and work status – and susceptibility to dementia, and SES changes throughout a person’s life, known as social mobility, seem to influence this risk; however, scientific ...

Researchers discover hidden step in dinosaur feather evolution

Researchers discover hidden step in dinosaur feather evolution
Scientists discover ‘zoned development’ in dinosaur skin, with zones of reptile-style scales and zones of bird-like skin with feathers New dinosaur skin fossil found to be composed of silica – the same as glass Discovery sheds light on evolution from scales to feathers Palaeontologists at University College Cork (UCC) in Ireland have discovered that some feathered dinosaurs had scaly skin like reptiles today, thus shedding new light on the evolutionary transition from scales to feathers. The researchers studied a new specimen of the feathered dinosaur Psittacosaurus from the early Cretaceous ...

Studies reveal cell-by-cell changes caused when pig hearts and kidneys are transplanted into humans

Surgical teams at NYU Langone Health performed the world’s first genetically modified pig kidney transplants into a human body in September and November 2021, and then transplanted two pig hearts in the summer of 2022. These procedures were done in patients declared dead based on neurologic criteria (decedents) and maintained on ventilators with the consent of their families. Demonstrating the field’s progress, NYU Langone in April 2024 transplanted a pig kidney into a living patient. Now two new analyses, one published online on May 17 in Nature Medicine and the other May ...


Discovery of spontaneous inflow and outflow states of high-temperature plasma by energetic ions

Tax the rich, say a majority of adults across 17 G20 countries surveyed

Semaglutide leads to greater weight loss in women than men with HF, improves HF symptoms in both sexes

12.5, the 1st Impact Factor of COMMTR released!

Circadian clock impact on cluster headaches funded by $2.4M NIH grant for UTHealth Houston research

Study identifies first drug therapy for sleep apnea

How old is your bone marrow?

Boosting biodiversity without hurting local economies

ChatGPT is biased against resumes with credentials that imply a disability — but it can improve

Simple test for flu could improve diagnosis and surveillance

UT Health San Antonio researcher awarded five-year, $2.53 million NIH grant to study alcohol-assisted liver disease

Giving pre-med students hands-on clinical training

CAMH research suggests potential targets for prevention and early identification of psychotic disorders

Mapping the heart to prevent damage caused by a heart attack

Study challenges popular idea that Easter islanders committed ‘ecocide’

Chilling discovery: Study reveals evolution of human cold and menthol sensing protein, offering hope for future non-addictive pain therapies.

Elena Beccalli, new rector of Università Cattolica del Sacro Cuore, takes office on 1st July

Pacific Northwest Research Institute uncovers hidden DNA mechanisms of rare genetic diseases

Empowering older adults: Wearable tech made easier with personalized support

Pennington Biomedical researchers partner on award-winning Long Covid study

Cooling ‘blood oranges’ could make them even healthier – a bonus for consumers

Body image and overall health found important to the sexual health of older gay men, according to new studies

Lab-grown muscles reveal mysteries of rare muscle diseases

Primary hepatic angiosarcoma: Treatment options for a rare tumor

Research finds causal evidence tying cerebral small-vessel disease to Alzheimer’s, dementia

Navigating the Pyrocene: Recent Cell Press papers on managing fire risk

Restoring the Great Salt Lake would have environmental justice as well as ecological benefits

Cannabis, tobacco use, and COVID-19 outcomes

A 5:2 intermittent fasting meal replacement diet and glycemic control for adults with diabetes

Scientists document self-propelling oxygen decline in the oceans

[] Does managing oxidative stress hold the key to effectively treating Alzheimer’s disease
Supplement to the Journal of Alzheimer’s Disease highlights oxidative stress-based research into potential therapeutic targets and protective drugs for managing Alzheimer’s disease